Reply

1. Agnoli A, Ruggieri S, Falaschi P, et al: Domperidone induced hyperprolactinemia improves clinical symptoms in Parkinson's disease: possible effect of prolactin at nigro-striatal level. In MacLeod RM, Scapagnini U (eds): Central and Peripheral Regulation of Prolactin Function. New York, Raven, 1980, pp 347-3 5 1 2. Hruska RE, Ludmer LM, Silbergeld EK: The striaral dopamine receptor supersensitivity produced by estrogen may be mediated through prolactin. Abstracts of the 10th Annual Meeting of the Society for Neuroscience, 1980, p 441 3. Ludmer LM, Hruska RE: Hypophysectomy prevents the striatal dopamine receptor supersensitivity produced by chronic haloperidol treatment. Abstracts of the 10th Annual Meeting of the Society for Neuroscience, 1980, p 441 4. Parkes JD, Schachter M, Marsden CD, Smith B, Wilson A: Lisuride in parkinsonism. Ann Neurol 9:48-52, 1981 5 . Perkins NA, Westfall TC: The effect of prolactin on dopamine release from rat striatum and medial basal hypothalamus. Neuroscience 3 : 5 9-63, 1978 6. Perkins NA, Westfall TC, Paul CV, et al: Effect of prolactin on dopamine synthesis in medial basal hypothalamus: evidence for short loop feedback. Brain Res 160:431-444, 1979